Fasting ghrelin levels are not elevated in children with hypothalamic obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 5, 2005, Pages 2691-2695

  Kanumakala, S ^a   Greaves, R ^b   Pedreira, C C ^b   Donath, S ^b   Warne, G L ^b   Zacharin, M R ^b   Harris, Mark ^c  

^a ALEXANDRA HOSPITAL   (United Kingdom)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c MATER CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCOSE; INSULIN; LEPTIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMIC OBESITY; INFANT; INSULIN BLOOD LEVEL; MALE; OBESITY; PRIORITY JOURNAL; WEIGHT GAIN;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; FASTING; FEMALE; HUMANS; HYPOTHALAMUS; INSULIN; LEPTIN; MALE; OBESITY, MORBID; PEPTIDE HORMONES; PRADER-WILLI SYNDROME;

EID: 18844381102     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-2175     Document Type: Article

References (30)

1. Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT 2004 Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89:81-86
2. Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenbom R, Bettendorf M, Kuhl J, Gutjahr P, Sorensen N, Calaminus G 2001 Obesity after childhood craniopharyngioma-German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 213:244-249
3. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
4. Spiegelman BM, Flier JS 2001 Obesity and the regulation of energy balance. Cell 104:531-543
5. Cassidy SB 1997 Prader-Willi syndrome. J Med Genet 34:917-923
6. Swaab D 1997 Prader-Willi syndrome and the hypothalamus. Acta Paediatr Suppl 423:50-54
7. Cummings D, Clement K, Purnell J, Vaisse C, Foster KE, Frayo S, Schwartz M, Basdevant A, Weigle D 2002 Elevated plasma ghrelin levels in Prader-Willi syndrome. Nat Med 8:643-644
8. Haqq AM, Farooqi IS, O'Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, LaFranchi SH, Purnell JQ 2003 Serum ghrelin levels are inversely correlated with body mass index, age and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 88:174-178
9. Del Parigi A, Tschop M, Heiman ML, Salbe AD, Vozarova B, Sell SM, Bunt JC, Tataranni PA 2002 High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 87:5461-5464
10. Tauber M, Conte Auriol F, Moulin P, Molinas C, Delagnes V, Salles JP 2004 Hyperghrelinaemia is a common feature of Prader-Willi syndrome and pituitary stalk interruption: a pathophysiological hypothesis. Horm Res 62:49-54
11. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH 2000 Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1-6
12. McCarthy HD, Jarrett KV, Crawley HF 2001 The development of waist circumference percentiles in British children aged 5.0-16.9 years. Eur J Clin Nutr 55:902-907
13. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
14. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV, Sherwin RS 2003 The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284:E313-E316
15. Saad MF, Bernaba B, Hwu C, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R 2002 Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87:3997-4000
16. Chan JL, Bullen J, Lee JH, Yiannakouris N, Mantzoros CS 2004 Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 89:335-343
17. Eiholzer U, Stutz K, Weinmann C, Torresani T, Molinari L, Prader A 1998 Low insulin, 1GF-1 and 1GFBP3 levels in children with Prader-Labhart-Willi syndrome. Eur J Paediatr 157:890-893
18. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X 2003 Octreotide therapy of pediatric hypothalamic obesity: a double-blind placebo-controlled trial. J Clin Endocrinol Metab 88:2586-2592
19. Gabreels BA, Swaab DF, de Kleijn DP, Seidah NG, Van de Loo JW, Van de Ven WJ, Martens GJ, van Leeuwen FW 1998 Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect. J Clin Endocrinol Metab 83:591-599
20. Harz KJ, Muller HL, Waldeck E, Pudel V, Roth C 2003 Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88:5227-5231
21. le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR 2005 Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab 90:1068-1071
22. Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva F, Deghenghi R, Camanni F, Ghigo E 2001 Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a non-natural peptidyl GHS and GH-releasing hormone. J Clin Endocrinol Metab 86:1169-1174
23. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ 2002 Human plasma ghrelin levels after diet-induced weight loss and gastric bypass surgery. N Engl J Med 346:1623-1630
24. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S 2002 Plasma ghrelin levels in lean and obese humans and effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240-244
25. Tan TM, Vanderpump M, Khoo B, Patterson M, Ghatei MA, Goldstone AP 2004 Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 89:4162-4165
26. Kojima M, Hosoda H, Matsuo H, Kangawa K 2001 Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2:118-122
27. Muccioli G, Tschop M, Papotti M, Deghengi R, Heiman M, Ghigo E 2002 Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. 2002 Eur J Pharmacol 440:235-254
28. Broglio F, Gottero C, Prodam F, Guana C, Muccioli G, Papotti M, Abribat T, van der Lely AJ, Ghigo E 2004 Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Endocrinol Invest 89:3062-3065
29. Vivenza D, Rapa A, Castellino N, Bellone S, Petri A, Vacca G, Aimaretti G, Broglio F, Bona G 2004 Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. Eur J Endocrinol 151:127-133
30. Groschl M, Uhr M, Kraus T 2004 Evaluation of the comparability of commercial ghrelin assays. Clin Chem 50:457-458